Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Clinical and functional connectivity outcomes of 5-Hz repeated transcranial magnetic stimulation as an add-on treatment in cocaine use disorder: a double-blind randomized controlled trial

View ORCID ProfileEduardo A. Garza-Villarreal, Ruth Alcala-Lozano, Sofia Fernandez-Lozano, Erik Morelos-Santana, Alan Dávalos, Viviana Villicaña, View ORCID ProfileSarael Alcauter, View ORCID ProfileF. Xavier Castellanos, Jorge J. Gonzalez-Olvera
doi: https://doi.org/10.1101/2020.07.15.20154708
Eduardo A. Garza-Villarreal
1Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM) campus Juriquilla, Queretaro, Mexico
2Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eduardo A. Garza-Villarreal
  • For correspondence: egarza@comunidad.unam.mx
Ruth Alcala-Lozano
2Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sofia Fernandez-Lozano
2Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”, Mexico City, Mexico
3Faculty of Psychology, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Morelos-Santana
2Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”, Mexico City, Mexico
3Faculty of Psychology, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Dávalos
2Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”, Mexico City, Mexico
4Faculty of Medicine, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viviana Villicaña
2Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”, Mexico City, Mexico
5Faculty of Psychology, Universidad Anahuac Sur, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarael Alcauter
1Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM) campus Juriquilla, Queretaro, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarael Alcauter
F. Xavier Castellanos
6Department of Child and Adolescent Psychiatry, NYU Grossman School of Medicine, New York, NY, USA
7Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for F. Xavier Castellanos
Jorge J. Gonzalez-Olvera
2Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría “Ramón de la Fuente Muñiz”, Mexico City, Mexico
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

BACKGROUND Cocaine use disorder (CUD) is a global condition lacking effective treatment. Repeated magnetic transcranial stimulation (rTMS) may reduce craving and frequency of cocaine use, but little is known about its efficacy and neural effects.

OBJECTIVE/HYPOTHESIS We sought to elucidate short- and long-term clinical benefits of 5-Hz rTMS as an add-on to standard treatment in CUD patients and discern underlying functional connectivity (FC) effects using magnetic resonance imaging.

METHODS Forty-four CUD patients were randomly assigned to complete the 2-week double-blind randomized controlled trial (acute phase) [Sham (n=20, 2 female) and Active (n=24, 4 female)], in which they received 2 daily sessions of rTMS on the left dorsolateral prefrontal cortex. Subsequently, 20 CUD patients continued to an open-label maintenance phase for 6 months (2 weekly sessions for up to 6 months).

RESULTS rTMS plus standard treatment for 2 weeks significantly reduced craving (p = 0.013, d=0.77) and impulsivity (p = 0.011, d=0.79) in the Active group. We also found increased FC between lDLPFC-vmPFC and vmPFC-right angular gyrus Clinical and functional connectivity effects were maintained for 3 months but they dissipated by 6 months. We did not observe reduction of positive cocaine urine tests, however, self-reported frequency and grams consumed for 6 months were reduced.

CONCLUSIONS With this RCT we show that 5-Hz rTMS has potential promise as an adjunctive treatment for CUD and merits further research.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT02986438

Funding Statement

This study was supported by public funds CONACYT FOSISS No. 0260971 and CONACYT No. 253072. Student scholarships were provided by CONACYT for: Sofia Fernandez-Lozano No. 476284, Alan Davalos No.581492 and Erik Morelos-Santana No. 479345.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted at the Clinical Research Division of the National Institute of Psychiatry in Mexico City, Mexico, and all procedures were approved by the Institutional Ethics Research Committee (CEI/C/070/2016).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • This manuscript was reviewed by peers and the it was corrected accordingly.

Data Availability

Data and code are freely available. Main project website including code, data and statistical analyses: https://github.com/egarza/sudmex_tms_main; defaced raw data in BIDS format: https://openneuro.org/datasets/ds003037/versions/1.0.0; some derivatives: https://zenodo.org/record/3967527#.XzMDdXX0k5k; brain maps: https://neurovault.org/collections/8519/. More derivatives (i.e. fMRIprep outputs) available by request.

https://github.com/egarza/sudmex_tms_main

https://www.medrxiv.org/content/10.1101/2020.07.15.20154708v1

https://openneuro.org/datasets/ds003037/versions/1.0.0

https://zenodo.org/record/3967527#.XzMDdXX0k5k

https://neurovault.org/collections/8519/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Clinical and functional connectivity outcomes of 5-Hz repeated transcranial magnetic stimulation as an add-on treatment in cocaine use disorder: a double-blind randomized controlled trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Clinical and functional connectivity outcomes of 5-Hz repeated transcranial magnetic stimulation as an add-on treatment in cocaine use disorder: a double-blind randomized controlled trial
Eduardo A. Garza-Villarreal, Ruth Alcala-Lozano, Sofia Fernandez-Lozano, Erik Morelos-Santana, Alan Dávalos, Viviana Villicaña, Sarael Alcauter, F. Xavier Castellanos, Jorge J. Gonzalez-Olvera
medRxiv 2020.07.15.20154708; doi: https://doi.org/10.1101/2020.07.15.20154708
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Clinical and functional connectivity outcomes of 5-Hz repeated transcranial magnetic stimulation as an add-on treatment in cocaine use disorder: a double-blind randomized controlled trial
Eduardo A. Garza-Villarreal, Ruth Alcala-Lozano, Sofia Fernandez-Lozano, Erik Morelos-Santana, Alan Dávalos, Viviana Villicaña, Sarael Alcauter, F. Xavier Castellanos, Jorge J. Gonzalez-Olvera
medRxiv 2020.07.15.20154708; doi: https://doi.org/10.1101/2020.07.15.20154708

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (140)
  • Anesthesia (44)
  • Cardiovascular Medicine (404)
  • Dentistry and Oral Medicine (66)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (168)
  • Epidemiology (4771)
  • Forensic Medicine (2)
  • Gastroenterology (172)
  • Genetic and Genomic Medicine (666)
  • Geriatric Medicine (69)
  • Health Economics (187)
  • Health Informatics (614)
  • Health Policy (312)
  • Health Systems and Quality Improvement (198)
  • Hematology (83)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5240)
  • Intensive Care and Critical Care Medicine (322)
  • Medical Education (88)
  • Medical Ethics (23)
  • Nephrology (72)
  • Neurology (674)
  • Nursing (41)
  • Nutrition (109)
  • Obstetrics and Gynecology (123)
  • Occupational and Environmental Health (203)
  • Oncology (435)
  • Ophthalmology (137)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (34)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (128)
  • Primary Care Research (82)
  • Psychiatry and Clinical Psychology (757)
  • Public and Global Health (1784)
  • Radiology and Imaging (315)
  • Rehabilitation Medicine and Physical Therapy (135)
  • Respiratory Medicine (254)
  • Rheumatology (86)
  • Sexual and Reproductive Health (67)
  • Sports Medicine (59)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)